Plasmodium falciparum gametocytes: With a view to a kill

Parasitology

Volumn 140, Issue 14, 2013, Pages 1718-1734

  Butterworth, Alice S ^a,b   Skinner Adams, Tina S ^c   Gardiner, Don L ^b,d   Trenholme, Katharine R ^a,b  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c GRIFFITH UNIVERSITY   (Australia)

^d JAMES COOK UNIVERSITY   (Australia)

Author keywords

antimalarials; drugs; gametocytes; malaria; Plasmodium falciparum; transmission blocking

Indexed keywords

ACRIDINE DERIVATIVE; AMODIAQUINE; ANTIMALARIAL AGENT; ARTEETHER; ARTEMETHER; ARTEMISININ; ARTEMISININ DERIVATIVE; ARTEROLANE; ARTESUNATE; ATOVAQUONE; BULAQUINE; CHLOROQUINE; CYANOCOBALAMIN; DECOQUINATE; ENDOPEROXIDE; HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE INHIBITOR; MEFLOQUINE; NATURAL PRODUCT; OZ 439; PIPERAQUINE; PRIMAQUINE; PRIMAQUINE DERIVATIVE; PYRONARIDINE; QUINOLINE; RIBOFLAVIN; TAFENOQUINE; UNCLASSIFIED DRUG;

ASEXUAL REPRODUCTION; BLOOD; CLINICAL TRIAL (TOPIC); DISEASE TRANSMISSION; DRUG TARGETING; GAMETOCYTE; HUMAN; MALARIA; MALARIA CONTROL; MORPHOLOGY; NONHUMAN; PLASMODIUM CYNOMOLGI; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; REVIEW;

ANTIMALARIALS; GERM CELLS; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM;

EID: 84887929500     PISSN: 00311820     EISSN: 14698161     Source Type: Journal    
DOI: 10.1017/S0031182013001236     Document Type: Review

References (223)

1. Adjalley, S. H., Johnston, G. L., Li, T., Eastman, R. T., Ekland, E. H., Eappen, A. G., Richman, A., Sim, B. K., Lee, M. C., Hoffman, S. L. and Fidock, D. A. (2011). Quantitative assessment of Plasmodium falciparum sexual development reveals potent transmission-blocking activity by methylene blue. Proceedings of the National Academy of Sciences USA 108, E1214-E1223. doi: 10.1073/pnas.1112037108
2. Aikawa, M. and Beaudoin, R. L. (1970). Plasmodium fallax: Highresolution autoradiography of exoerythrocytic stages treated with Primaquine in vitro. Experimental Parasitology 27, 454-463
3. Akompong, T., Eksi, S., Williamson, K. and Haldar, K. (2000a). Gametocytocidal activity and synergistic interactions of riboflavin with standard antimalarial drugs against growth of Plasmodium falciparum in vitro. Antimicrobial Agents and Chemotherapy 44, 3107-3111
4. Akompong, T., Ghori, N. and Haldar, K. (2000b). In vitro activity of riboflavin against the human malaria parasite Plasmodium falciparum. Antimicrobial Agents and Chemotherapy 44, 88-96
5. Alano, P. and Carter, R. (1990). Sexual differentiation in malaria parasites. Annual Review of Microbiology 44, 429-449. doi: 10.1146/ annurev.mi.44.100190.002241
6. Alving, A. S., Arnold, J. and Robinson, D. H. (1952). Mass therapy of subclinical vivax malaria with primaquine. Journal of the American Medical Association 149, 1558-1562
7. Alving, A. S., Carson, P. E., Flanagan, C. L. and Ickes, C. E. (1956). Enzymatic deficiency in primaquine-sensitive erythrocytes. Science 124, 484-485
8. Aminake, M. N., Schoof, S., Sologub, L., Leubner, M., Kirschner, M., Arndt, H. D. and Pradel, G. (2011). Thiostrepton and derivatives exhibit antimalarial and gametocytocidal activity by dually targeting parasite proteasome and apicoplast. Antimicrobial Agents and Chemotherapy 55, 1338-1348. doi: 10.1128/AAC.01096-10
9. Anders, J. C., Chung, H. and Theoharides, A. D. (1988). Methemoglobin formation resulting from administration of candidate 8-Aminoquinoline antiparasitic drugs in the dog. Fundamental and Applied Toxicology 10, 270-275
10. Andrews, K. T., Fairlie, D. P., Madala, P. K., Ray, J., Wyatt, D. M., Hilton, P. M., Melville, L. A., Beattie, L., Gardiner, D. L., Reid, R. C., Stoermer, M. J., Skinner-Adams, T., Berry, C. and McCarthy, J. S. (2006). Potencies of human immunodeficiency virus protease inhibitors in vitro against Plasmodium falciparum and in vivo against murine malaria. Antimicrobial Agents and Chemotherapy 50, 639-648. doi: 10.1128/ AAC.50.2.639-648.2006
11. Arango, E. M., Upegui, Y. A. and Carmona-Fonseca, J. (2012). Efficacy of different primaquine-based antimalarial regimens against Plasmodium falciparum gametocytemia. Acta Tropica 122, 177-182. doi: 10.1016/j. actatropica.2012.01. 005
12. Arora, K. and Srivastava, A. K. (2005). Antimalarial efficacy of methylene blue and menadione and their effect on glutathione metabolism of Plasmodium yoelii-infected albino mice. Parasitology Research 97, 521-526. doi: 10.1007/s00436-005-1478-4
13. Atamna, H., Krugliak, M., Shalmiev, G., Deharo, E., Pescarmona, G. and Ginsburg, H. (1996). Mode of antimalarial effect of methylene blue and some of its analogues on Plasmodium falciparum in culture and their inhibition of P. vinckei petteri and P. yoelii nigeriensis in vivo. Biochemical Pharmacology 51, 693-700
14. Auparakkitanon, S., Chapoomram, S., Kuaha, K., Chirachariyavej, T. and Wilairat, P. (2006). Targeting of hematin by the antimalarial pyronaridine. Antimicrobial Agents and Chemotherapy 50, 2197-2200. doi: 10.1128/AAC.00119-06
15. Avula, B., Tekwani, B. L., Chaurasiya, N. D., Nanayakkara, N. D., Wang, Y. H., Khan, S. I., Adelli, V. R., Sahu, R., Elsohly, M. A., McChesney, J. D., Khan, I. A. and Walker, L. A. (2013). Profiling primaquine metabolites in primary human hepatocytes using UHPLCQTOF-MS with (13) C stable isotope labeling. Journal of Mass Spectrometry 48, 276-285. doi: 10.1002/jms.3122
16. Baird, J. K. and Hoffman, S. L. (2004). Primaquine therapy for malaria. Clinical Infectious Diseases 39, 1336-1345. doi: 10.1086/424663
17. Baird, J. K., McCormick, G. J. and Canfield, C. J. (1986). Effects of nine synthetic putative metabolites of primaquine on activity of the hexose monophosphate shunt in intact human red blood cells in vitro. Biochemical Pharmacology 35, 1099-1106. 0006-2952(86)90145-0 [pii]
18. Baker, D. A. (2010). Malaria gametocytogenesis. Molecular and Biochemical Parasitology 172, 57-65. doi: 10.1016/j.molbiopara.2010.03.019
19. Baker, J. K., Yarber, R. H., Nanayakkara, N. P., McChesney, J. D., Homo, F. and Landau, I. (1990). Effect of aliphatic side-chain substituents on the antimalarial activity and on the metabolism of primaquine studied using mitochondria and microsome preparations. Pharmaceutical Research 7, 91-95
20. Baldwin, J., Michnoff, C. H., Malmquist, N. A., White, J., Roth, M. G., Rathod, P. K. and Phillips, M. A. (2005). High-Throughput screening for potent and selective inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase. Journal of Biological Chemistry 280, 21847-21853. doi: 10.1074/jbc.M501100200
21. Barnes, K. I., Little, F., Mabuza, A., Mngomezulu, N., Govere, J., Durrheim, D., Roper, C., Watkins, B. and White,N. J. (2008). Increased gametocytemia after treatment: An early parasitological indicator of emerging sulfadoxine-pyrimethamine resistance in falciparum malaria. Journal of Infectious Diseases 197, 1605-1613. doi: 10.1086/587645
22. Basco, L. K. and Le Bras, J. (1993). In vitro activity of monodesethylamodiaquine and amopyroquine against African isolates and clones of Plasmodium falciparum. American Journal of Tropical Medicine and Hygiene 48, 120-125
23. Bates, M. D., Meshnick, S. R., Sigler, C. I., Leland, P. and Hollingdale, M. R. (1990). In vitro effects of primaquine and primaquine metabolites on exoerythrocytic stages of Plasmodium berghei. American Journal of Tropical Medicine and Hygiene 42, 532-537
24. Baty, J. D., Price Evans, D. A. and Robinson, P. A. (1975). The identification of 6-Methoxy 8-Aminoquinoline as a metabolite in man. Biomedical Mass Spectronomy 2, 304-306
25. Beaudoin, R. L. and Aikawa, M. (1968). Primaquine-induced changes in morphology of exoerythrocytic stages of malaria. Science 160, 1233-1234
26. Benoit-Vical, F., Lelievre, J., Berry, A., Deymier, C., Dechy-Cabaret, O., Cazelles, J., Loup, C., Robert, A., Magnaval, J. F. and Meunier, B. (2007). Trioxaquines are new antimalarial agents active on all erythrocytic forms, including gametocytes. Antimicrobial Agents and Chemotherapy 51, 1463-1472. doi: 10.1128/AAC.00967-06
27. Billker, O., Shaw, M. K., Jones, I.W., Ley, S. V., Mordue, A. J. and Sinden, R. E. (2002). Azadirachtin disrupts formation of organised microtubule arrays during microgametogenesis of Plasmodium berghei. Journal of Eukaryotic Microbiology 49, 489-497
28. Blank, O., Davioud-Charvet, E. and Elhabiri, M. (2012). Interactions of the antimalarial drug methylene blue with methemoglobin and heme targets in Plasmodium falciparum: A physico-biochemical study. Antioxidants and Redox Signaling 17, 544-554. doi: 10.1089/ars.2011.4239
29. Bolchoz, L. J., Budinsky, R. A., McMillan, D. C. and Jollow, D. J. (2001). Primaquine-induced hemolytic anemia: Formation and hemotoxicity of the arylhydroxylamine metabolite 6-methoxy-8-hydroxylaminoquinoline. Journal of Pharmacology and Experimental Therapeutics 297, 509-515
30. Boulard, Y., Landau, I., Miltgen, F., Ellis, D. S. and Peters, W. (1983). The chemotherapy of rodent malaria, XXXIV. Causal prophylaxis Part III: Ultrastructural changes induced in exo-erythrocytic schizonts of Plasmodium yoelii yoelii by primaquine. Annals of Tropical Medicine and Parasitology 77, 555-568
31. Bountogo, M., Zoungrana, A., Coulibaly, B., Klose, C., Mansmann, U., Mockenhaupt, F. P., Burhenne, J., Mikus, G., Walter-Sack, I., Schirmer, R. H., Sie, A., Meissner, P. and Muller, O. (2009). Efficacy of methylene blue monotherapy in semiimmune adults with uncomplicated falciparum malaria: A controlled trial in Burkina Faso. Tropical Medicine and International Health 15, 713-717. doi: 10.1111/j.1365-3156.2010.02526.x.
32. Bousema, T., Okell, L., Shekalaghe, S., Griffin, J. T., Omar, S., Sawa, P., Sutherland, C., Sauerwein, R., Ghani, A. C. and Drakeley, C. (2010). Revisiting the circulation time of Plasmodium falciparum gametocytes: Molecular detection methods to estimate the duration of gametocyte carriage and the effect of gametocytocidal drugs. Malaria Journal 9, 136. doi: 10.1186/1475-2875-9-136
33. Brueckner, R. P., Coster, T., Wesche, D. L., Shmuklarsky, M. and Schuster, B. G. (1998a). Prophylaxis of Plasmodium falciparum infection in a human challenge model with WR 238605, a new 8-Aminoquinoline antimalarial. Antimicrobial Agents and Chemotherapy 42, 1293-1294
34. Brueckner, R. P., Lasseter, K. C., Lin, E. T. and Schuster, B. G. (1998b). First-Time-in-humans safety and pharmacokinetics of WR 238605, a new antimalarial. American Journal of Tropical Medicine and Hygiene 58, 645-649
35. Buchholz, K., Schirmer, R. H., Eubel, J. K., Akoachere, M. B., Dandekar, T., Becker, K. and Gromer, S. (2008). Interactions of methylene blue with human disulfide reductases and their orthologues from Plasmodium falciparum. Antimicrobial Agents and Chemotherapy 52, 183-191. doi: 10.1128/AAC.00773-07
36. Buchholz, K., Burke, T. A., Williamson, K. C., Wiegand, R. C., Wirth, D. F. and Marti, M. (2011). A high-Throughput screen targeting malaria transmission stages opens new avenues for drug development. Journal of Infectious Diseases 203, 1445-1453. doi: 10.1093/infdis/jir037
37. Buckling, A. G., Taylor, L. H., Carlton, J. M. and Read, A. F. (1997). Adaptive changes in Plasmodium transmission strategies following chloroquine chemotherapy. Proceedings of the Royal Society B, Biological Science 264, 553-559. doi: 10.1098/rspb.1997.0079
38. Buckling, A., Ranford-Cartwright, L. C., Miles, A. and Read, A. F. (1999). Chloroquine increases Plasmodium falciparum gametocytogenesis in vitro. Parasitology 118(Pt 4), 339-346
39. Buffet, P. A., Safeukui, I., Deplaine, G., Brousse, V., Prendki, V., Thellier, M., Turner, G. D. and Mercereau-Puijalon, O. (2011). The pathogenesis of Plasmodium falciparum malaria in humans: Insights from splenic physiology. Blood 117, 381-392. doi: 10.1182/blood-2010-04202911
40. Burgess, R.W. and Bray, R. S. (1961). The effect of a single dose of primaquine on the gametocytes, gametogony and sporogony of Laverania falciparum. Bulletin of the World Health Organization 24, 451-456
41. Butcher, G. A. and Sinden, R. E. (2003). Persistence of atovaquone in human sera following treatment: Inhibition of Plasmodium falciparum development in vivo and in vitro. American Journal of Tropical Medicine and Hygiene 68, 111-114
42. Butler, A. R., Gilbert, B. C., Hulme, P., Irvine, L. R., Renton, L. and Whitwood, A. C. (1998). EPR evidence for the involvement of free radicals in the iron-catalysed decomposition of qinghaosu (artemisinin) and some derivatives; antimalarial action of some polycyclic endoperoxides. Free Radical Research 28, 471-476
43. Campbell, C. C., Chin, W., Collins, W. E. and Moss, D. M. (1980). Infection of Anopheles freeborni by gametocytes of cultured Plasmodium falciparum. Transactions of the Royal Society of Tropical Medicine and Hygiene 74, 668-669
44. Canning, E. U. and Sinden, R. E. (1975). Nuclear organisation in gametocytes of Plasmodium and hepatocystis: A cytochemical study. Zeitschrift fur Parasitenkunde 46, 297-299
45. Carter, R. and Miller, L. H. (1979). Evidence for environmental modulation of gametocytogenesis in Plasmodium falciparum in continuous culture. Bulletin of the World Health Organization 57(Suppl. 1), 37-52
46. Carvalho, L., Luque-Ortega, J. R., Manzano, J. I., Castanys, S., Rivas, L. and Gamarro, F. (2010). Tafenoquine, an antiplasmodial 8-Aminoquinoline, targets leishmania respiratory complex III and induces apoptosis. Antimicrobial Agents and Chemotherapy 54, 5344-5351. doi: 10.1128/AAC.00790-10
47. Cervantes, S., Stout, P. E., Prudhomme, J., Engel, S., Bruton, M., Cervantes, M., Carter, D., Tae-Chang, Y., Hay, M. E., Aalbersberg, W., Kubanek, J. and Le Roch, K. G. (2012). High content live cell imaging for the discovery of new antimalarial marine natural products. BMC Infectious Diseases 12, 1. doi: 10.1186/1471-2334-12-1
48. Charles, B. G., Miller, A. K., Nasveld, P. E., Reid, M. G., Harris, I. E. and Edstein, M. D. (2007). Population pharmacokinetics of tafenoquine during malaria prophylaxis in healthy subjects. Antimicrobial Agents and Chemotherapy 51, 2709-2715. doi: 10.1128/AAC.01183-06
49. Chavalitshewinkoon-Petmitr, P., Pongvilairat, G., Auparakkitanon, S. and Wilairat, P. (2000). Gametocytocidal activity of pyronaridine and DNA topoisomerase II inhibitors against multidrug-resistant Plasmodium falciparum in vitro. Parasitology International 48, 275-280. doi: S1383576999000288
50. Chavalitshewinkoon-Petmitr, P., Pongvilairat, G., Ralph, R. K., Denny, W. A. and Wilairat, P. (2001). Inhibitory effects of 9-Anilinoacridines on Plasmodium falciparum gametocytes. Tropical Medicine and International Health 6, 42-45
51. Chen, P. Q., Li, G. Q., Guo, X. B., He, K. R., Fu, Y. X., Fu, L. C. and Song, Y. Z. (1994). The infectivity of gametocytes of Plasmodium falciparum from patients treated with artemisinin. Chinese Medical Journal 107, 709-711
52. Chevalley, S., Coste, A., Lopez, A., Pipy, B. and Valentin, A. (2010). Flow cytometry for the evaluation of anti-plasmodial activity of drugs on Plasmodium falciparum gametocytes. Malaria Journal 9, 49. doi: 10.1186/ 1475-2875-9-49
53. Childs, G. E., Boudreau, E. F., Milhous, W. K., Wimonwattratee, T., Pooyindee, N., Pang, L. and Davidson, D. E., Jr. (1989). A comparison of the in vitro activities of amodiaquine and desethylamodiaquine against isolates of Plasmodium falciparum. American Journal of Tropical Medicine and Hygiene 40, 7-11
54. Chotivanich, K., Sattabongkot, J., Udomsangpetch, R., Looareesuwan, S., Day, N. P., Coleman, R. E. and White, N. J. (2006). Transmission-blocking activities of quinine, primaquine, and artesunate. Antimicrobial Agents and Chemotherapy 50, 1927-1930. doi: 10.1128/AAC.01472-05
55. Clark, A. M., Baker, J. K. and McChesney, J.D. (1984a). Excretion, distribution, and metabolism of primaquine in rats. Journal of Pharmaceutical Sciences 73, 502-506
56. Clark, A. M., Hufford, C. D., Gupta, R. C., Puri, R. K. and McChesney, J. D. (1984b). Microbial transformation of primaquine by Candida tropicalis. Applied and Environmental Microbiology 47, 537-539
57. Coleman, R. E. (1990). Sporontocidal activity of the antimalarial WR-238605 against Plasmodium berghei ANKA in Anopheles stephensi. American Journal of Tropical Medicine and Hygiene 42, 196-205
58. Coleman, R. E., Clavin, A. M. and Milhous, W. K. (1992). Gametocytocidal and sporontocidal activity of antimalarials against Plasmodium berghei ANKA in ICR mice and Anopheles stephensi mosquitoes. American Journal of Tropical Medicine and Hygiene 46, 169-182
59. Cosledan, F., Fraisse, L., Pellet, A., Guillou, F., Mordmuller, B., Kremsner, P. G., Moreno, A., Mazier, D., Maffrand, J. P. and Meunier, B. (2008). Selection of a trioxaquine as an antimalarial drug candidate. Proceedings of the National Academy of Sciences USA 105, 17579-17584. doi: 10.1073/pnas. 0804338105
60. Coulibaly, B., Zoungrana, A., Mockenhaupt, F. P., Schirmer, R. H., Klose, C., Mansmann, U., Meissner, P. E. and Muller, O. (2009). Strong gametocytocidal effect of methylene blue-based combination therapy against falciparum malaria: A randomised controlled trial. PLoS ONE 4, e5318. doi: 10.1371/journal.pone. 0005318
61. Croft, S. L., Duparc, S., Arbe-Barnes, S. J., Craft, J. C., Shin, C. S., Fleckenstein, L., Borghini-Fuhrer, I. and Rim, H. J. (2012). Review of pyronaridine anti-malarial properties and product characteristics. Malaria Journal 11, 270. doi: 10.1186/1475-2875-11-270
62. Cui, L. and Su, X. Z. (2009). Discovery, mechanisms of action and combination therapy of artemisinin. Expert Review of Anti-Infective Therapy 7, 999-1013. doi: 10.1586/eri.09.68
63. Cumming, J. N., Ploypradith, P. and Posner, G. H. (1997). Antimalarial activity of artemisinin (qinghaosu) and related trioxanes: Mechanism(s) of action. Advances in Pharmacology 37, 253-297
64. Czesny, B., Goshu, S., Cook, J. L. and Williamson, K. C. (2009). The proteasome inhibitor epoxomicin has potent Plasmodium falciparum gametocytocidal activity. Antimicrobial Agents and Chemotherapy 53, 4080-4085. doi: 10.1128/AAC.00088-09
65. da Cruz, F. P., Martin, C., Buchholz, K., Lafuente-Monasterio, M. J., Rodrigues, T., Sonnichsen, B., Moreira, R., Gamo, F. J., Marti, M., Mota, M. M., Hannus, M. and Prudencio, M. (2012). Drug screen targeted at Plasmodium liver stages identifies a potent multistage antimalarial drug. Journal of InfectiousDiseases 205, 1278-1286. doi: 10.1093/infdis/jis184
66. Darling, S. (1910). Studies in relation to malaria. In Isthmanian Canal Commission 1910 (ed. Laboratory of the Board of Health, I.C.C.), pp. 3-38. Washington Government Printing Office, Washington, DC, USA
67. Day, K. P., Karamalis, F., Thompson, J., Barnes, D. A., Peterson, C., Brown, H., Brown, G. V. and Kemp, D. J. (1993). Genes necessary for expression of a virulence determinant and for transmission of Plasmodium falciparum are located on a 0•3-megabase region of chromosome 9. Proceedings of the National Academy of Sciences USA 90, 8292-8296
68. Dechy-Cabaret, O. and Benoit-Vical, F. (2012). Effects of antimalarial molecules on the gametocyte stage of Plasmodium falciparum: The debate. Journal of Medicinal Chemistry 55, 10328-10344. doi: 10.1021/ jm3005898
69. Dechy-Cabaret, O., Benoit-Vical, F., Robert, A. and Meunier, B. (2000). Preparation and antimalarial activities of trioxaquines, new modular molecules with a trioxane skeleton linked to a 4-Aminoquinoline. ChemBioChem 1, 281-283
70. Dechy-Cabaret, O., Benoit-Vical, F., Loup, C., Robert, A., Gornitzka, H., Bonhoure, A., Vial, H., Magnaval, J. F., Seguela, J. P. and Meunier, B. (2004). Synthesis and antimalarial activity of trioxaquine derivatives. Chemistry 10, 1625-1636. doi: 10.1002/chem.200305576
71. Deharo, E., Garcia, R. N., Oporto, P., Gimenez, A., Sauvain, M., Jullian, V. and Ginsburg, H. (2002). A non-radiolabelled ferriprotoporphyrin IX biomineralisation inhibition test for the high throughput screening of antimalarial compounds. Experimental Parasitology 100, 252-256. doi: S0014489402000279
72. Delves, M., Plouffe, D., Scheurer, C., Meister, S., Wittlin, S., Winzeler, E. A., Sinden, R. E. and Leroy, D. (2012). The activities of current antimalarial drugs on the life cycle stages of Plasmodium: A comparative study with human and rodent parasites. PLoS Medicine 9, e1001169. doi: 10.1371/journal.pmed.1001169
73. Dixon, M.W., Peatey, C. L., Gardiner, D. L. and Trenholme, K. R. (2009). A green fluorescent protein-based assay for determining gametocyte production in Plasmodium falciparum. Molecular and Biochemical Parasitology 163, 123-126. doi: 10.1016/j.molbiopara.2008.10.004
74. Duffy, S. and Avery, V. M. (2012). Development and optimization of a novel 384-well anti-malarial imaging assay validated for high-Throughput screening. American Journal of Tropical Medicine and Hygiene 86, 84-92. doi: 10.4269/ajtmh.2012.11-0302
75. Dunyo, S., Milligan, P., Edwards, T., Sutherland, C., Targett, G. and Pinder, M. (2006). Gametocytaemia after drug treatment of asymptomatic Plasmodium falciparum. PLoS Clinical Trials 1, e20. doi: 10.1371/journal. pctr.0010020
76. Dyer, M. and Day, K. P. (2000). Commitment to gametocytogenesis in Plasmodium falciparum. Parasitology Today 16, 102-107. doi: S0169-4758 (99)01608-7
77. Edstein, M. D., Kocisko, D. A., Brewer, T. G., Walsh, D. S., Eamsila, C. and Charles, B. G. (2001). Population pharmacokinetics of the new antimalarial agent tafenoquine in Thai soldiers. British Journal of Clinical Pharmacology 52, 663-670
78. Edstein, M. D., Kocisko, D. A., Walsh, D. S., Eamsila, C., Charles, B. G. and Rieckmann, K. H. (2003). Plasma concentrations of tafenoquine, a new long-Acting antimalarial agent, in Thai soldiers receiving monthly prophylaxis. Clinical Infectious Diseases 37, 1654-1658. doi: 10.1086/379718 CID31533
79. Elmes, N. J., Nasveld, P. E., Kitchener, S. J., Kocisko, D. A. and Edstein, M. D. (2008). The efficacy and tolerability of three different regimens of tafenoquine versus primaquine for post-exposure prophylaxis of Plasmodium vivax malaria in the Southwest Pacific. Transactions of the Royal Society of Tropical Medicine and Hygiene 102, 1095-1101. doi: 10.1016/j.trstmh.2008.04.024
80. Enosse, S., Butcher, G. A., Margos, G., Mendoza, J., Sinden, R. E. and Hogh, B. (2000). The mosquito transmission of malaria: The effects of atovaquone-proguanil (Malarone) and chloroquine. Transactions of the Royal Society of Tropical Medicine and Hygiene 94, 77-82
81. Farber, P. M., Arscott, L. D., Williams, C. H., Jr., Becker, K. and Schirmer, R. H. (1998). Recombinant Plasmodium falciparum glutathione reductase is inhibited by the antimalarial dye methylene blue. FEBS Letters 422, 311-314
82. Farfour, E., Charlotte, F., Settegrana, C., Miyara, M. and Buffet, P. (2012). The extravascular compartment of the bone marrow: A niche for Plasmodium falciparum gametocyte maturation? Malaria Journal 11, 285. doi: 10.1186/1475-2875-11-285
83. Figgitt, D., Denny, W., Chavalitshewinkoon, P., Wilairat, P. and Ralph, R. (1992). In vitro study of anticancer acridines as potential antitrypanosomal and antimalarial agents. Antimicrobial Agents and Chemotherapy 36, 1644-1647
84. Fisk, T. L., Millet, P., Collins, W. E. and Nguyen-Dinh, P. (1989). In vitro activity of antimalarial compounds on the exoerythrocytic stages of Plasmodium cynomolgi and P. knowlesi. American Journal of Tropical Medicine and Hygiene 40, 235-239
85. Fivelman, Q. L., McRobert, L., Sharp, S., Taylor, C. J., Saeed, M., Swales, C. A., Sutherland, C. J. and Baker, D. A. (2007). Improved synchronous production of Plasmodium falciparum gametocytes in vitro. Molecular and Biochemical Parasitology 154, 119-123. doi: 10.1016/j. molbiopara.2007.04.008
86. Fleck, S. L., Pudney, M. and Sinden, R. E. (1996). The effect of atovaquone (566C80) on the maturation and viability of Plasmodium falciparum gametocytes in vitro. Transactions of the Royal Society of Tropical Medicine and Hygiene 90, 309-312
87. Fletcher, K. A., Barton, P. F. and Kelly, J. A. (1988). Studies on the mechanisms of oxidation in the erythrocyte by metabolites of primaquine. Biochemical Pharmacology 37, 2683-2690
88. Foltz, L. M., Dalal, B. I., Wadsworth, L. D., Broady, R., Chi, K., Eisenhauer, E., Kobayashi, K. and Kollmannsburger, C. (2006). Recognition and management of methemoglobinemia and hemolysis in a G6PD-deficient patient on experimental anticancer drug Triapine. American Journal of Hematology 81, 210-211. doi: 10.1002/ajh.20547
89. Fry, M. and Pudney, M. (1992). Site of action of the antimalarial hydroxynaphthoquinone, 2-[trans-4-(4′-chlorophenyl) cyclohexyl]-3-hydroxy- 1,4-naphthoquinone (566C80). Biochemical Pharmacology 43, 1545-1553
90. Gamage, S. A., Tepsiri, N., Wilairat, P., Wojcik, S. J., Figgitt, D. P., Ralph, R. K. and Denny,W. A. (1994). Synthesis and in vitro evaluation of 9-Anilino-3,6-diaminoacridines active against a multidrug-resistant strain of the malaria parasite Plasmodium falciparum. Journal of Medicinal Chemistry 37, 1486-1494
91. Gamo, F. J., Sanz, L. M., Vidal, J., de Cozar, C., Alvarez, E., Lavandera, J. L., Vanderwall, D. E., Green, D. V., Kumar, V., Hasan, S., Brown, J. R., Peishoff, C. E., Cardon, L. R. and Garcia-Bustos, J. F. (2010). Thousands of chemical starting points for antimalarial lead identification. Nature 465, 305-310. nature09107 [pii] 10.1038/ nature09107
92. Ganesan, S., Tekwani, B. L., Sahu, R., Tripathi, L. M. and Walker, L. A. (2009). Cytochrome P(450)-dependent toxic effects of primaquine on human erythrocytes. Toxicology and Applied Pharmacology 241, 14-22. doi: 10.1016/j.taap.2009.07.012
93. Gauthier, T.W. (2000). Methylene blue-induced hyperbilirubinemia in neonatal glucose-6-phosphate dehydrogenase (G6PD) deficiency. Journal of Maternal-Fetal Medicine 9, 252-254
94. Ginsburg, H., Famin, O., Zhang, J. and Krugliak, M. (1998). Inhibition of glutathione-dependent degradation of heme by chloroquine and amodiaquine as a possible basis for their antimalarial mode of action. Biochemical Pharmacology 56, 1305-1313
95. Gogtay, N. J., Kamtekar, K. D., Dalvi, S. S., Mehta, S. S., Chogle, A. R., Aigal, U. and Kshirsagar, N. A. (2006). A randomized, parallel study of the safety and efficacy of 45 mg primaquine versus 75 mg bulaquine as gametocytocidal agents in adults with blood schizonticideresponsive uncomplicated falciparum malaria [ISCRTN50134587]. BMC Infectious Diseases 6, 16. doi: 10.1186/1471-2334-6-16
96. Grande, T., Bernasconi, A., Erhart, A., Gamboa, D., Casapia, M., Delgado, C., Torres, K., Fanello, C., Llanos-Cuentas, A. and Dálessandro, U. (2007). A randomised controlled trial to assess the efficacy of dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Peru. PLoS ONE 2, e1101. doi: 10.1371/ journal.pone.0001101
97. Graves, P. M., Carter, R. and McNeill, K. M. (1984). Gametocyte production in cloned lines of Plasmodium falciparum. American Journal of Tropical Medicine and Hygiene 33, 1045-1050
98. Graves, P. M., Gelband, H. and Garner, P. (2012). Primaquine for reducing Plasmodium falciparum transmission. Cochrane Database System Review 9, CD008152. doi: 0.1002/14651858.CD008152.pub2
99. Greaves, J., Price-Evans, D. A., Gilles, H. M. and Baty, J. D. (1979). A selected ion monitoring assay for primaquine in plasma and urine. Biomedical Mass Spectrometry 6, 109-112. doi: 10.1002/bms.1200060306
100. Guiguemde,W. A., Shelat, A. A., Bouck, D., Duffy, S., Crowther, G. J., Davis, P. H., Smithson, D. C., Connelly, M., Clark, J., Zhu, F., Jimenez-Diaz, M. B., Martinez, M. S., Wilson, E. B., Tripathi, A. K., Gut, J., Sharlow, E. R., Bathurst, I., El Mazouni, F., Fowble, J.W., Forquer, I., McGinley, P. L., Castro, S., Angulo-Barturen, I., Ferrer, S., Rosenthal, P. J., Derisi, J. L., Sullivan, D. J., Lazo, J. S., Roos, D. S., Riscoe, M. K., Phillips, M. A., Rathod, P. K., Van Voorhis, W. C., Avery, V. M. and Guy, R. K. (2010). Chemical genetics of Plasmodium falciparum. Nature 465, 311-315. doi: 10.1038/ nature09099
101. Guiguemde, W. A., Shelat, A. A., Garcia-Bustos, J. F., Diagana, T. T., Gamo, F. J. and Guy, R. K. (2012). Global phenotypic screening for antimalarials. Chemistry and Biology 19, 116-129. doi: 10.1016/j.chembiol. 2012.01.004
102. Hale, B. R., Owusu-Agyei, S., Fryauff, D. J., Koram, K. A., Adjuik, M., Oduro, A. R., Prescott,W. R., Baird, J. K., Nkrumah, F., Ritchie, T. L., Franke, E. D., Binka, F. N., Horton, J. and Hoffman, S. L. (2003). A randomized, double-blind, placebo-controlled, dose-ranging trial of tafenoquine for weekly prophylaxis against Plasmodium falciparum. Clinical Infectious Diseases 36, 541-549. doi: 10.1086/367542
103. Hanada, M., Sugawara, K., Kaneta, K., Toda, S., Nishiyama, Y., Tomita, K., Yamamoto, H., Konishi, M. and Oki, T. (1992). Epoxomicin, a new antitumor agent of microbial origin. Journal of Antibiotics 45, 1746-1752
104. Hanssen, E., Knoechel, C., Dearnley, M., Dixon, M.W., Le Gros, M., Larabell, C. and Tilley, L. (2011). Soft X-ray microscopy analysis of cell volume and hemoglobin content in erythrocytes infected with asexual and sexual stages of Plasmodium falciparum. Journal of Structural Biology 177, 224-232. doi: 10.1016/j.jsb.2011.09.003
105. Hatz, C., Abdulla, S., Mull, R., Schellenberg, D., Gathmann, I., Kibatala, P., Beck, H. P., Tanner, M. and Royce, C. (1998). Efficacy and safety of CGP 56697 (artemether and benflumetol) compared with chloroquine to treat acute falciparum malaria in Tanzanian children aged 1-5 years. Tropical Medicine and International Health 3, 498-504
106. Hawking, F., Wilson, M. E. and Gammage, K. (1971). Evidence for cyclic development and short-lived maturity in the gametocytes of Plasmodium falciparum. Transactions of the Royal Society of Tropical Medicine and Hygiene 65, 549-559
107. Haynes, R. K. and Vonwiller, S. C. (1994). Extraction of artemisinin and artemisinic acid: Preparation of artemether and new analogues. Transactions of the Royal Society of Tropical Medicine and Hygiene 88(Suppl. 1), S23-S26
108. Haynes, R. K., Cheu, K.W., Tang, M. M., Chen, M. J., Guo, Z. F., Guo, Z. H., Coghi, P. and Monti, D. (2011). Reactions of antimalarial peroxides with each of leucomethylene blue and dihydroflavins: Flavin reductase and the cofactor model exemplified. ChemMedChem 6, 279-291. doi: 10.1002/cmdc.201000508
109. Hobbs, C. V., Voza, T., Coppi, A., Kirmse, B., Marsh, K., Borkowsky, W. and Sinnis, P. (2009). HIV protease inhibitors inhibit the development of preerythrocytic-stage plasmodium parasites. Journal of Infectious Diseases 199, 134-141. doi: 10.1086/594369
110. Hobbs, C. V., Tanaka, T. Q., Muratova, O., Van Vliet, J., Borkowsky, W., Williamson, K. C. and Duffy, P. E. (2013). HIV treatments have malaria gametocyte killing and transmission blocking activity. Journal of Infectious Diseases 208, 139-148. doi: 10.1093/infdis/jit132
111. Howes, R. E., Piel, F. B., Patil, A. P., Nyangiri, O. A., Gething, P.W., Dewi, M., Hogg, M. M., Battle, K. E., Padilla, C. D., Baird, J. K. and Hay, S. I. (2012). G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: A geostatistical model-based map. PLoS Medicine 9, e1001339. doi: 10.1371/journal. pmed.1001339
112. Hufford, C. D., Clark, A. M., Quinones, I. N., Baker, J. K. and McChesney, J. D. (1983). Microbial metabolism studies on the major microbial and mammalian metabolite of primaquine. Journal of Pharmaceutical Sciences 72, 92-94
113. Hufford, C. D., Baker, J. K., McChesney, J. D. and Clark, A. M. (1986). Novel sulfur-containing microbial metabolite of primaquine. Antimicrobial Agents and Chemotherapy 30, 234-237
114. Idowu, O. R., Peggins, J. O., Brewer, T. G. and Kelley, C. (1995). Metabolism of a candidate 8-Aminoquinoline antimalarial agent, WR 238605, by rat liver microsomes. Drug Metabolism and Disposition: The Biological Fate of Chemicals 23, 1-17
115. Ifediba, T. and Vanderberg, J. P. (1981). Complete in vitro maturation of Plasmodium falciparum gametocytes. Nature 294, 364-366
116. Ikilezi, G., Achan, J., Kakuru, A., Ruel, T., Charlebois, E., Clark, T. D., Rosenthal, P. J., Havlir, D., Kamya, M. R. and Dorsey, G. (2013). Prevalence of asymptomatic parasitemia and gametocytemia among HIV-infected Ugandan children randomized to receive different antiretroviral therapies. American Journal of Tropical Medicine and Hygiene 88, 744-746. doi: 10.4269/ajtmh.12-0658
117. Ittarat, I., Asawamahasakda, W. and Meshnick, S. R. (1994). The effects of antimalarials on the Plasmodium falciparum dihydroorotate dehydrogenase. Experimental Parasitology 79, 50-56. doi: 10.1006/ expr.1994.1058
118. Jeffery, G. M., Young, M. D. and Eyles, D. E. (1956). The treatment of Plasmodium falciparum infection with chloroquine, with a note on infectivity to mosquitoes of primaquine-And pyrimethamine-Treated cases. American Journal of Tropical Medicine and Hygiene 64, 1-11
119. Jiang, J. B., Li, G. Q., Guo, X. B., Kong, Y. C. and Arnold, K. (1982). Antimalarial activity of mefloquine and qinghaosu. Lancet 2, 285-288
120. Jusko, W. J. and Levy, G. (1967). Absorption, metabolism, and excretion of riboflavin-5′-phosphate in man. Journal of Pharmaceutical Sciences 56, 58-62
121. Kamtekar, K. D., Gogtay, N. J., Dalvi, S. S., Karnad, D. R., Chogle, A. R., Aigal, U. and Kshirsagar, N. A. (2004). A prospective study evaluating the efficacy of a single, 45-mg dose of primaquine, as a gametocytocidal agent, in patients with Plasmodium falciparum malaria in Mumbai, India. Annals of Tropical Medicine and Parasitology 98, 453-458. doi: 10.1179/000349804225003550
122. Kato, M., Tanabe, K., Miki, A., Ichimori, K. and Waki, S. (1990). Membrane potential of Plasmodium falciparum gametocytes monitored with rhodamine 123. FEMS Microbiology Letters 57, 283-288
123. Kelner, M. J. and Alexander, N. M. (1985). Methylene blue directly oxidizes glutathione without the intermediate formation of hydrogen peroxide. Journal of Biological Chemistry 260, 15168-15171
124. Kiszewski, A. (2011). Blocking Plasmodium falciparum malaria transmission with drugs: The gametocytocidal and sporontocidal properties of current and prospective antimalarials. Pharmaceuticals 4, 44-68
125. Kolaczinski, K., Leslie, T., Ali, I., Durrani, N., Lee, S., Barends, M., Beshir, K., Ord, R., Hallett, R. and Rowland, M. (2012). Defining Plasmodium falciparum treatment in South West Asia: A randomized trial comparing artesunate or primaquine combined with chloroquine or SP. PLoS ONE 7, e28957. doi: 10.1371/journal.pone.0028957
126. Krungkrai, J., Prapunwattana, P. and Krungkrai, S. R. (2000). Ultrastructure and function of mitochondria in gametocytic stage of Plasmodium falciparum. Parasite 7, 19-26
127. Kumar, N. and Zheng, H. (1990). Stage-specific gametocytocidal effect in vitro of the antimalaria drug qinghaosu on Plasmodium falciparum. Parasitology Research 76, 214-218
128. Kurosawa, Y., Dorn, A., Kitsuji-Shirane, M., Shimada, H., Satoh, T., Matile, H., Hofheinz,W., Masciadri, R., Kansy, M. and Ridley, R. G. (2000). Hematin polymerization assay as a high-Throughput screen for identification of new antimalarial pharmacophores. Antimicrobial Agents and Chemotherapy 44, 2638-2644
129. Kurth, F., Pongratz, P., Belard, S., Mordmuller, B., Kremsner, P. G. and Ramharter, M. (2009). In vitro activity of pyronaridine against Plasmodium falciparum and comparative evaluation of anti-malarial drug susceptibility assays. Malaria Journal 8, 79. doi: 10.1186/1475-2875-8-79
130. Lanners, H. N. (1991). Effect of the 8-Aminoquinoline primaquine on culture-derived gametocytes of the malaria parasite Plasmodium falciparum. Parasitology Research 77, 478-481
131. Lederman, E. R., Maguire, J. D., Sumawinata, I.W., Chand, K., Elyazar, I., Estiana, L., Sismadi, P., Bangs, M. J. and Baird, J. K. (2006). Combined chloroquine, sulfadoxine/pyrimethamine and primaquine against Plasmodium falciparum in Central Java, Indonesia. Malaria Journal 5, 108. doi: 10.1186/1475-2875-5-108
132. Lelievre, J., Almela, M. J., Lozano, S., Miguel, C., Franco, V., Leroy, D. and Herreros, E. (2012). Activity of clinically relevant antimalarial drugs on Plasmodium falciparum mature gametocytes in an ATP bioluminescence transmission blocking assay. PLoS ONE 7, e35019. doi: 10.1371/journal.pone. 0035019
133. Lell, B., Faucher, J. F., Missinou, M. A., Borrmann, S., Dangelmaier, O., Horton, J. and Kremsner, P. G. (2000). Malaria chemoprophylaxis with tafenoquine: A randomised study. Lancet 355, 2041-2045. doi: 10.1016/S0140-6736(00)02352-7
134. Lucantoni, L. and Avery, V. (2012). Whole-cell in vitro screening for gametocytocidal compounds. Future Medicinal Chemistry 4, 2337-2360. doi: 10.4155/fmc.12.188
135. Mandi, G., Witte, S., Meissner, P., Coulibaly, B., Mansmann, U., Rengelshausen, J., Schiek, W., Jahn, A., Sanon, M., Wust, K., Walter-Sack, I., Mikus, G., Burhenne, J., Riedel, K. D., Schirmer, H., Kouyate, B. and Muller, O. (2005). Safety of the combination of chloroquine and methylene blue in healthy adult men with G6PD deficiency from rural Burkina Faso. Tropical Medicine and International Health 10, 32-38. doi: 10.1111/j.1365-3156.2004.01356.x.
136. McGowan, S., Porter, C. J., Lowther, J., Stack, C. M., Golding, S. J., Skinner-Adams, T. S., Trenholme, K. R., Teuscher, F., Donnelly, S. M., Grembecka, J., Mucha, A., Kafarski, P., Degori, R., Buckle, A. M., Gardiner, D. L., Whisstock, J. C. and Dalton, J. P. (2009). Structural basis for the inhibition of the essential Plasmodium falciparum M1 neutral aminopeptidase. Proceedings of the National Academy of Sciences USA 106, 2537-2542. doi: 10.1073/ pnas.0807398106
137. McKenzie, F. E., Jeffery, G. M. and Collins, W. E. (2007). Gametocytemia and fever in human malaria infections. Journal of Parasitology 93, 627-633. doi: 10.1645/GE-1052R.1
138. Meissner, P. E., Mandi, G., Witte, S., Coulibaly, B., Mansmann, U., Rengelshausen, J., Schiek, W., Jahn, A., Sanon, M., Tapsoba, T., Walter-Sack, I., Mikus, G., Burhenne, J., Riedel, K. D., Schirmer, H., Kouyate, B. and Muller, O. (2005). Safety of the methylene blue plus chloroquine combination in the treatment of uncomplicated falciparum malaria in young children of Burkina Faso [ISRCTN27290841]. Malaria Journal 4, 45. doi: 10.1186/1475-2875-4-45
139. Meissner, P. E., Mandi, G., Coulibaly, B., Witte, S., Tapsoba, T., Mansmann, U., Rengelshausen, J., Schiek, W., Jahn, A., Walter-Sack, I., Mikus, G., Burhenne, J., Riedel, K. D., Schirmer, R. H., Kouyate, B. and Muller, O. (2006). Methylene blue for malaria in Africa: Results from a dose-finding study in combination with chloroquine. Malaria Journal 5, 84. doi: 10.1186/1475-2875-5-84
140. Mens, P. F., Sawa, P., van Amsterdam, S. M., Versteeg, I., Omar, S. A., Schallig, H. D. and Kager, P. A. (2008). A randomized trial to monitor the efficacy and effectiveness by QT-NASBA of artemetherlumefantrine versus dihydroartemisinin-piperaquine for treatment and transmission control of uncomplicated Plasmodium falciparum malaria in western Kenya. Malaria Journal 7, 237. doi: 10.1186/1475-2875-7-237
141. Meshnick, S. R. (2002). Artemisinin: Mechanisms of action, resistance and toxicity. International Journal for Parasitology 32, 1655-1660. doi: S0020751902001947
142. Meshnick, S. R., Taylor, T. E. and Kamchonwongpaisan, S. (1996). Artemisinin and the antimalarial endoperoxides: From herbal remedy to targeted chemotherapy. Microbiological Reviews 60, 301-315
143. Mihaly, G.W., Ward, S. A., Edwards, G., Orme, M. L. and Breckenridge, A. M. (1984). Pharmacokinetics of primaquine in man: Identification of the carboxylic acid derivative as a major plasma metabolite. British Journal of Clinical Pharmacology 17, 441-446
144. Mihaly, G.W., Ward, S. A., Edwards, G., Nicholl, D. D., Orme, M. L. and Breckenridge, A. M. (1985). Pharmacokinetics of primaquine in man. I. Studies of the absolute bioavailability and effects of dose size. British Journal of Clinical Pharmacology 19, 745-750
145. Miller, M. J., Marcus, D. M. and Cameron, D. G. (1965). Latent infections with Plasmodium ovale malaria. Canadian Medical Association Journal 92, 1241-1247
146. Morris, C. A., Duparc, S., Borghini-Fuhrer, I., Jung, D., Shin, C. S. and Fleckenstein, L. (2011). Review of the clinical pharmacokinetics of artesunate and its active metabolite dihydroartemisinin following intravenous, intramuscular, oral or rectal administration. Malaria Journal 10, 263. doi: 10.1186/1475-2875-10-263
147. Muller, O., Mockenhaupt, F. P., Marks, B., Meissner, P., Coulibaly, B., Kuhnert, R., Buchner, H., Schirmer, R. H., Walter-Sack, I., Sie, A. and Mansmann, U. (2012). Haemolysis risk in methylene blue treatment of G6PD-sufficient and G6PD-deficient West-African children with uncomplicated falciparum malaria: A synopsis of four RCTs. Pharmacoepidemiology and Drug Safety 22, 376-385. doi: 10.1002/ pds.3370
148. Nasveld, P. E., Edstein, M. D., Reid, M., Brennan, L., Harris, I. E., Kitchener, S. J., Leggat, P. A., Pickford, P., Kerr, C., Ohrt, C. and Prescott, W. (2010). Randomized, double-blind study of the safety, tolerability, and efficacy of tafenoquine versus mefloquine for malaria prophylaxis in nonimmune subjects. Antimicrobial Agents and Chemotherapy 54, 792-798. doi: 10.1128/AAC.00354-09
149. Ndayiragije, A., Niyungeko, D., Karenzo, J., Niyungeko, E., Barutwanayo, M., Ciza, A., Bosman, A., Moyou-Somo, R., Nahimana, A., Nyarushatsi, J. P., Barihuta, T., Mizero, L., Ndaruhutse, J., Delacollette, C., Ringwald, P. and Kamana, J. (2004). Efficacy of therapeutic combinations with artemisinin derivatives in the treatment of non complicated malaria in Burundi. Tropical Medicine and International Health 9, 673-679. doi: 10.1111/j.1365-3156.2004. 01255.x.
150. Ni, Y. C., Xu, Y. Q. and Wang, M. J. (1992). Rat liver microsomal and mitochondrial metabolism of primaquine in vitro. Zhongguo Yao Li Xue Bao 13, 431-435
151. Obaldia, N. III, Rossan, R. N., Cooper, R. D., Kyle, D. E., Nuzum, E. O., Rieckmann, K.H. and Shanks, G. D. (1997). WR 238605, chloroquine, and their combinations as blood schizonticides against a chloroquine-resistant strain of Plasmodium vivax in Aotus monkeys. American Journal of Tropical Medicine and Hygiene 56, 508-510
152. Ochong, E. O., van den Broek, I. V., Keus, K. and Nzila, A. (2003). Short report: Association between chloroquine and amodiaquine resistance and allelic variation in the Plasmodium falciparum multiple drug resistance 1 gene and the chloroquine resistance transporter gene in isolates from the upper Nile in southern Sudan. American Journal of Tropical Medicine and Hygiene 69, 184-187
153. Okamoto, N., Spurck, T. P., Goodman, C. D. and McFadden, G. I. (2009). Apicoplast and mitochondrion in gametocytogenesis of Plasmodium falciparum. Eukaryotic Cell 8, 128-132. doi: 10.1128/EC.00267-08
154. Okombo, J., Kiara, S. M., Mwai, L., Pole, L., Ohuma, E., Ochola, L. I. and Nzila, A. (2011). Baseline in vitro activities of the antimalarials pyronaridine and methylene blue against Plasmodium falciparum isolates from Kenya. Antimicrobial Agents and Chemotherapy 56, 1105-1107. doi: 10.1128/AAC.05454-11
155. Pastrana-Mena, R., Dinglasan, R. R., Franke-Fayard, B., Vega-Rodriguez, J., Fuentes-Caraballo, M., Baerga-Ortiz, A., Coppens, I., Jacobs-Lorena, M., Janse, C. J. and Serrano, A. E. (2010). Glutathione reductase-null malaria parasites have normal blood stage growth but arrest during development in the mosquito. Journal of Biological Chemistry 285, 27045-27056. doi: 10.1074/jbc.M110.122275
156. Peatey, C. L., Andrews, K. T., Eickel, N., MacDonald, T., Butterworth, A. S., Trenholme, K. R., Gardiner, D. L., McCarthy, J. S. and Skinner-Adams, T. S. (2009a). Antimalarial asexual stage-specific and gametocytocidal activities of HIV protease inhibitors. Antimicrobial Agents and Chemotherapy 54, 1334-1337. doi: 10.1128/ AAC.01512-09
157. Peatey, C. L., Skinner-Adams, T. S., Dixon, M.W., McCarthy, J. S., Gardiner, D. L. and Trenholme, K. R. (2009b). Effect of antimalarial drugs on Plasmodium falciparum gametocytes. Journal of Infectious Diseases 200, 1518-1521. doi: 10.1086/644645
158. Peatey, C. L., Spicer, T. P., Hodder, P. S., Trenholme, K. R. and Gardiner, D. L. (2011). A high-Throughput assay for the identification of drugs against late-stage Plasmodium falciparum gametocytes. Molecular and Biochemical Parasitology 180, 127-131. doi: 10.1016/j.molbiopara. 2011.09.002
159. Peatey, C. L., Leroy, D., Gardiner, D. L. and Trenholme, K. R. (2012). Anti-malarial drugs: How effective are they against Plasmodium falciparum gametocytes? Malaria Journal 11, 34. doi: 10.1186/1475-2875-11-34
160. Peters,W., Robinson, B. L. and Milhous,W. K. (1993). The chemotherapy of rodent malaria.LI. Studies on a new 8-Aminoquinoline,WR238,605. Annals of Tropical Medicine and Parasitology 87, 547-552
161. Phillips, M. A. and Rathod, P. K. (2010). Plasmodium dihydroorotate dehydrogenase: A promising target for novel anti-malarial chemotherapy. Infectious Disorders Drug Targets 10, 226-239
162. Plouffe, D., Brinker, A., McNamara, C., Henson, K., Kato, N., Kuhen, K., Nagle, A., Adrian, F., Matzen, J. T., Anderson, P., Nam, T. G., Gray, N. S., Chatterjee, A., Janes, J., Yan, S. F., Trager, R., Caldwell, J. S., Schultz, P. G., Zhou, Y. and Winzeler, E. A. (2008). In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-Throughput screen. Proceedings of the National Academy of Sciences USA 105, 9059-9064. doi: 10.1073/pnas.0802982105
163. Ponnudurai, T., Meuwissen, J. H., Leeuwenberg, A. D., Verhave, J. P. and Lensen, A. H. (1982). The production of mature gametocytes of Plasmodium falciparum in continuous cultures of different isolates infective to mosquitoes. Transactions of the Royal Society of Tropical Medicine and Hygiene 76, 242-250
164. Portela, M. J., Moreira, R., Valente, E., Constantino, L., Iley, J., Pinto, J., Rosa, R., Cravo, P. and do Rosario, V. E. (1999). Dipeptide derivatives of primaquine as transmission-blocking antimalarials: Effect of aliphatic side-chain acylation on the gametocytocidal activity and on the formation of carboxyprimaquine in rat liver homogenates. Pharmaceutical Research 16, 949-955
165. Posner, G. H., Oh, C. H., Wang, D., Gerena, L., Milhous, W. K., Meshnick, S. R. and Asawamahasadka, W. (1994). Mechanism-based design, synthesis, and in vitro antimalarial testing of new 4-methylated trioxanes structurally related to artemisinin: The importance of a carboncentered radical for antimalarial activity. Journal of Medicinal Chemistry 37, 1256-1258
166. Pradines, B., Mabika Mamfoumbi, M., Parzy, D., Owono Medang, M., Lebeau, C., Mourou Mbina, J. R., Doury, J. C. and Kombila, M. (1999). In vitro susceptibility of African isolates of Plasmodium falciparum from Gabon to pyronaridine. American Journal of Tropical Medicine and Hygiene 60, 105-108
167. Pradines, B., Mamfoumbi, M. M., Tall, A., Sokhna, C., Koeck, J. L., Fusai, T., Mosnier, J., Czarnecki, E., Spiegel, A., Trape, J. F., Kombila, M. and Rogier, C. (2006). In vitro activity of tafenoquine against the asexual blood stages of Plasmodium falciparum isolates from Gabon, Senegal, and Djibouti. Antimicrobial Agents and Chemotherapy 50, 3225-3226. doi: 10.1128/AAC.00777-06
168. Price, R. N. and Douglas, N. M. (2009). Artemisinin combination therapy for malaria: Beyond good efficacy. Clinical Infectious Diseases 49, 1638-1640. doi: 10.1086/647947
169. Price, R. N., Nosten, F., Luxemburger, C., ter Kuile, F. O., Paiphun, L., Chongsuphajaisiddhi, T. and White, N. J. (1996). Effects of artemisinin derivatives onmalaria transmissibility. Lancet 347, 1654-1658
170. Priotto, G., Kabakyenga, J., Pinoges, L., Ruiz, A., Eriksson, T., Coussement, F., Ngambe, T., Taylor, W. R., Perea, W., Guthmann, J. P., Olliaro, P. and Legros, D. (2003). Artesunate and sulfadoxine-pyrimethamine combinations for the treatment of uncomplicated Plasmodium falciparum malaria in Uganda: A randomized, doubleblind, placebo-controlled trial. Transactions of the Royal Society of Tropical Medicine and Hygiene 97, 325-330
171. Pukrittayakamee, S., Chotivanich, K., Chantra, A., Clemens, R., Looareesuwan, S. and White, N. J. (2004). Activities of artesunate and primaquine against asexual-And sexual-stage parasites in falciparum malaria. Antimicrobial Agents and Chemotherapy 48, 1329-1334
172. Puri, S. K. and Dutta, G. P. (2003). Blood schizontocidal activity of WR 238605 (Tafenoquine) against Plasmodium cynomolgi and Plasmodium fragile infections in rhesus monkeys. Acta Tropica 86, 35-40. doi: S0001706X02002899
173. Puri, S. K. and Dutta, G. P. (2005). Plasmodium cynomolgi: Gametocytocidal activity of the anti-malarial compound CDRI 80/53 (elubaquine) in rhesus monkeys. Experimental Parasitology 111, 8-13. doi: 10.1016/j. exppara.2005.05.007
174. Redmond, A. M., Skinner-Adams, T., Andrews, K. T., Gardiner, D. L., Ray, J., Kelly, M. and McCarthy, J. S. (2007). Antimalarial activity of sera from subjects taking HIV protease inhibitors. AIDS 21, 763-765. doi: 10.1097/QAD.0b013e328031f41a.
175. Raabe, A. C., Billker, O., Vial, H. J. and Wengelnik, K. (2009). Quantitative assessment of DNA replication to monitor microgametogenesis in Plasmodium berghei. Molecular and Biochemical Parasitology 168, 172-176. doi: 10.1016/j.molbiopara.2009.08.004
176. Ribaut, C., Berry, A., Chevalley, S., Reybier, K.,Morlais, I., Parzy, D., Nepveu, F., Benoit-Vical, F. and Valentin, A. (2008). Concentration and purification by magnetic separation of the erythrocytic stages of all human Plasmodium species. Malaria Journal 7, 45. doi: 10.1186/1475-2875-7-45
177. Rieckmann, K. H., McNamara, J. V., Frischer, H., Stockert, T. A., Carson, P. E. and Powell, R. D. (1968). Gametocytocidal and sporontocidal effects of primaquine and of sulfadiazine with pyrimethamine in a chloroquine-resistant strain of Plasmodium falciparum. Bulletin of the World Health Organization 38, 625-632
178. Ringwald, P., Meche, F. S. and Basco, L. K. (1999). Short report: Effects of pyronaridine on gametocytes in patients with acute uncomplicated falciparum malaria. American Journal of Tropical Medicine and Hygiene 61, 446-448
179. Rohrich, C. R., Ngwa, C. J., Wiesner, J., Schmidtberg, H., Degenkolb, T., Kollewe, C., Fischer, R., Pradel, G. and Vilcinskas, A. (2012). Harmonine, a defence compound from the harlequin ladybird, inhibits mycobacterial growth and demonstrates multistage antimalarial activity. Biology Letters 8, 308-311. doi: 10.1098/ rsbl.2011.0760
180. Rosen, P. J., Johnson, C., McGehee, W. G. and Beutler, E. (1971). Failure of methylene blue treatment in toxic methemoglobinemia. Association with glucose-6-phosphate dehydrogenase deficiency. Annals of Internal Medicine 75, 83-86
181. Rottmann, M., McNamara, C., Yeung, B. K., Lee, M. C., Zou, B., Russell, B., Seitz, P., Plouffe, D. M., Dharia, N. V., Tan, J., Cohen, S. B., Spencer, K. R., Gonzalez-Paez, G. E., Lakshminarayana, S. B., Goh, A., Suwanarusk, R., Jegla, T., Schmitt, E. K., Beck, H. P., Brun, R., Nosten, F., Renia, L., Dartois, V., Keller, T. H., Fidock, D. A., Winzeler, E. A. and Diagana, T. T. (2010). Spiroindolones, a potent compound class for the treatment of malaria. Science 329, 1175-1180. doi: 10.1126/ science.1193225
182. Sachanonta, N., Chotivanich, K., Chaisri, U., Turner, G. D., Ferguson, D. J., Day, N. P. and Pongponratn, E. (2011). Ultrastructural and real-Time microscopic changes in P. falciparum-infected red blood cells following treatment with antimalarial drugs. Ultrastructural Pathology 35, 214-225. doi: 10.3109/01913123.2011.601405
183. Sarma, G. N., Savvides, S. N., Becker, K., Schirmer, M., Schirmer, R. H. and Karplus, P. A. (2003). Glutathione reductase of the malarial parasite Plasmodium falciparum: Crystal structure and inhibitor development. Journal of Molecular Biology 328, 893-907. doi: S0022283603003474
184. Saul, A., Graves, P. and Edser, L. (1990). Refractoriness of erythrocytes infected with Plasmodium falciparum gametocytes to lysis by sorbitol. International Journal for Parasitology 20, 1095-1097
185. Schirmer, R. H., Coulibaly, B., Stich, A., Scheiwein, M., Merkle, H., Eubel, J., Becker, K., Becher, H., Muller, O., Zich, T., Schiek,W. and Kouyate, B. (2003). Methylene blue as an antimalarial agent. Redox Report 8, 272-275. doi: 10.1179/135100003225002899
186. Schneider, E., Hsiang, Y. H. and Liu, L. F. (1990). DNA topoisomerases as anticancer drug targets. Advances in Pharmacology 21, 149-183
187. Shekalaghe, S., Drakeley, C., Gosling, R., Ndaro, A., van Meegeren, M., Enevold, A., Alifrangis, M., Mosha, F., Sauerwein, R. and Bousema, T. (2007). Primaquine clears submicroscopic Plasmodium falciparum gametocytes that persist after treatment with sulphadoxine-pyrimethamine and artesunate. PLoS ONE 2, e1023. doi: 10.1371/journal.pone.0001023
188. Sinden,R. E. (1982). Gametocytogenesis of Plasmodium falciparum in vitro: An electron microscopic study. Parasitology 84, 1-11
189. Sinden, R. E. and Smalley, M. E. (1979). Gametocytogenesis of Plasmodium falciparum in vitro: The cell-cycle. Parasitology 79, 277-296
190. Sinden, R. E., Canning, E. U., Bray, R. S. and Smalley, M. E. (1978). Gametocyte and gamete development in Plasmodium falciparum. Proceedings of the Royal Society of London. Series B: Biological Sciences 201, 375-399
191. Skinner-Adams, T. S., McCarthy, J. S., Gardiner, D. L., Hilton, P. M. and Andrews, K. T. (2004). Antiretrovirals as antimalarial agents. Journal of Infectious Diseases 190, 1998-2000. doi: 10.1086/425584
192. Skinner-Adams, T. S., Stack, C. M., Trenholme, K. R., Brown, C. L., Grembecka, J., Lowther, J., Mucha, A., Drag, M., Kafarski, P., McGowan, S., Whisstock, J. C., Gardiner, D. L. and Dalton, J. P. (2010). Plasmodium falciparum neutral aminopeptidases: New targets for anti-malarials. Trends in Biochemical Sciences 35, 53-61. doi: 10.1016/j. tibs.2009.08.004
193. Smalley, M. E. (1977). Plasmodium falciparum gametocytes: The effect of chloroquine on their development. Transactions of the Royal Society of Tropical Medicine and Hygiene 71, 526-529
194. Smalley, M. E., Abdalla, S. and Brown, J. (1981). The distribution of Plasmodium falciparum in the peripheral blood and bone marrow of Gambian children. Transactions of the Royal Society of Tropical Medicine and Hygiene 75, 103-105
195. Smithuis, F., Kyaw, M. K., Phe, O., Win, T., Aung, P. P., Oo, A. P., Naing, A. L., Nyo, M. Y., Myint, N. Z., Imwong, M., Ashley, E., Lee, S. J. and White, N. J. (2010). Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: An open-label randomised trial. Lancet Infectious Diseases 10, 673-681. doi: 10.1016/S1473-3099(10)70187-0
196. Sowunmi, A. and Fateye, B. A. (2003a). Plasmodium falciparum gametocytaemia in Nigerian children: Before, during and after treatment with antimalarial drugs. Tropical Medicine and International Health 8, 783-792
197. Sowunmi, A., Fateye, B. A., Happi, T. C., Gbotosho, G. O. and Oduola, A. M. (2003b). Plasmodium falciparum gametocytaemia in Nigerian children: Peripheral immature gametocytaemia as an indicator of a poor response to chloroquine treatment, and its relationship to molecular determinants of chloroquine resistance. Annals of Tropical Medicine and Parasitology 97, 453-468. doi: 10.1179/000349803235002443
198. Sowunmi, A., Balogun, T., Gbotosho, G. O., Happi, C. T., Adedeji, A. A. and Fehintola, F. A. (2007). Activities of amodiaquine, artesunate, and artesunate-Amodiaquine against asexual-And sexual-stage parasites in falciparum malaria in children. Antimicrobial Agents and Chemotherapy 51, 1694-1699. doi: 10.1128/AAC.00077-07
199. Sowunmi, A., Balogun, S. T., Gbotosho, G. O. and Happi, C. T. (2008). Plasmodium falciparum gametocyte sex ratios in children with acute, symptomatic, uncomplicated infections treated with amodiaquine. Malaria Journal 7, 169. doi: 10.1186/1475-2875-7-169
200. Sowunmi, A., Nkogho, O. O., Okuboyejo, T. M., Gbotosho, G. O., Happi, C. T. and Adewoye, E. O. (2009). Effects of mefloquine and artesunate mefloquine on the emergence, clearance and sex ratio of Plasmodium falciparum gametocytes in malarious children. Malaria Journal 8, 297. doi: 10.1186/1475-2875-8-297
201. Strother, A., Fraser, I. M., Allahyari, R. and Tilton, B. E. (1981). Metabolism of 8-Aminoquinoline antimalarial agents. Bulletin of the World Health Organization 59, 413-425
202. Strother, A., Allahyari, R., Buchholz, J., Fraser, I. M. and Tilton, B. E. (1984). In vitro metabolism of the antimalarial agent primaquine by mouse liver enzymes and identification of a methemoglobin-forming metabolite. Drug Metabolism and Disposition: The Biological Fate of Chemicals 12, 35-44
203. Suputtamongkol, Y., Chindarat, S., Silpasakorn, S., Chaikachonpatd, S., Lim, K., Chanthapakajee, K., Kaewkaukul, N. and Thamlikitkul, V. (2003). The efficacy of combined mefloquineartesunate versus mefloquine-primaquine on subsequent development of Plasmodium falciparum gametocytemia. American Journal of Tropical Medicine and Hygiene 68, 620-623
204. Tanaka, T. Q. and Williamson, K. C. (2011). A malaria gametocytocidal assay using oxidoreduction indicator, alamar blue. Molecular and Biochemical Parasitology 177, 160-163. doi: 10.1016/j.molbiopara.2011.02.005
205. Tanaka, T. Q., Dehdashti, S. J., Nguyen, D. T., McKew, J. C., Zheng,W. and Williamson, K. C. (2013). A quantitative high throughput assay for identifying gametocytocidal compounds. Molecular and Biochemical Parasitology 188, 20-25. doi: 10.1016/j.molbiopara.2013.02.005
206. Targett, G., Drakeley, C., Jawara, M., von Seidlein, L., Coleman, R., Deen, J., Pinder, M., Doherty, T., Sutherland, C., Walraven, G. and Milligan, P. (2001). Artesunate reduces but does not prevent posttreatment transmission of Plasmodium falciparum to Anopheles gambiae. Journal of Infectious Diseases 183, 1254-1259. doi: 10.1086/319689
207. Thurston, J. P. (1953). The chemotherapy of Plasmodium berghei. I. Resistance to drugs. Parasitology 43, 246-252
208. Trager, W. and Jensen, J. B. (1976). Human malaria parasites in continuous culture. Science 193, 673-675
209. Tshefu, A. K., Gaye, O., Kayentao, K., Thompson, R., Bhatt, K. M., Sesay, S. S., Bustos, D. G., Tjitra, E., Bedu-Addo, G., Borghini-Fuhrer, I., Duparc, S., Shin, C. S. and Fleckenstein, L. (2010). Efficacy and safety of a fixed-dose oral combination of pyronaridineartesunate compared with artemether- lumefantrine in children and adults with uncomplicated Plasmodium falciparum malaria: A randomised noninferiority trial. Lancet 375, 1457-1467. doi: 10.1016/S0140-6736(10) 60322-4
210. Udeinya, I. J., Brown, N., Shu, E. N., Udeinya, F. I. and Quakeyie, I. (2006). Fractions of an antimalarial neem-leaf extract have activities superior to chloroquine, and are gametocytocidal. Annals of Tropical Medicine and Parasitology 100, 17-22. doi: 10.1179/136485906X78508
211. Vaidya, A. B., Lashgari, M. S., Pologe, L. G. and Morrisey, J. (1993). Structural features of Plasmodium cytochrome b that may underlie susceptibility to 8-Aminoquinolines and hydroxynaphthoquinones. Molecular and Biochemical Parasitology 58, 33-42
212. Vale, N., Nogueira, F., do Rosario, V. E., Gomes, P. and Moreira, R. (2009). Primaquine dipeptide derivatives bearing an imidazolidin-4-one moiety at the N-Terminus as potential antimalarial prodrugs. European Journal of Medicinal Chemistry 44, 2506-2516. doi: 10.1016/j.ejmech. 2009.01.018
213. Vasquez-Vivar, J. and Augusto, O. (1992). Hydroxylated metabolites of the antimalarial drug primaquine. Oxidation and redox cycling. Journal of Biological Chemistry 267, 6848-6854
214. von Seidlein, L., Bojang, K., Jones, P., Jaffar, S., Pinder, M., Obaro, S., Doherty, T., Haywood, M., Snounou, G., Gemperli, B., Gathmann, I., Royce, C., McAdam, K. and Greenwood, B. (1998). A randomized controlled trial of artemether/benflumetol, a new antimalarial and pyrimethamine/ sulfadoxine in the treatment of uncomplicated falciparum malaria in African children. American Journal of Tropical Medicine and Hygiene 58, 638-644
215. Wainwright, M. and Amaral, L. (2005). The phenothiazinium chromophore and the evolution of antimalarial drugs. Tropical Medicine and International Health 10, 501-511. doi: 10.1111/j.1365-3156.2005.01417.x.
216. Walsh, D. S., Looareesuwan, S., Wilairatana, P., Heppner, D. G., Jr., Tang, D. B., Brewer, T. G., Chokejindachai, W., Viriyavejakul, P., Kyle, D. E., Milhous,W. K., Schuster, B. G., Horton, J., Braitman, D. J. and Brueckner, R. P. (1999). Randomized dose-ranging study of the safety and efficacy of WR 238605 (Tafenoquine) in the prevention of relapse of Plasmodium vivax malaria in Thailand. Journal of Infectious Diseases 180, 1282-1287. doi: 10.1086/315034
217. Walsh, D. S., Eamsila, C., Sasiprapha, T., Sangkharomya, S., Khaewsathien, P., Supakalin, P., Tang, D. B., Jarasrumgsichol, P., Cherdchu, C., Edstein, M. D., Rieckmann, K.H. and Brewer, T. G. (2004a). Efficacy of monthly tafenoquine for prophylaxis of Plasmodium vivax and multidrug-resistant P. falciparum malaria. Journal of Infectious Diseases 190, 1456-1463. doi: 10.1086/424468
218. Walsh, D. S., Wilairatana, P., Tang, D. B., Heppner, D. G., Jr., Brewer, T. G., Krudsood, S., Silachamroon, U.,Phumratanaprapin, W., Siriyanonda, D. and Looareesuwan, S. (2004b). Randomized trial of 3-dose regimens of tafenoquine (WR238605) versus low-dose primaquine for preventing Plasmodium vivax malaria relapse. Clinical Infectious Diseases 39, 1095-1103. doi: 10.1086/424508
219. Wilkinson, R. N., Noeypatimanondh, S. and Gould, D. J. (1976). Infectivity of falciparum malaria patients for anopheline mosquitoes before and after chloroquine treatment. Transactions of the Royal Society of Tropical Medicine and Hygiene 70, 306-307
220. Williams, J. L. (1999). Stimulation of Plasmodium falciparum gametocytogenesis by conditioned medium from parasite cultures. American Journal of Tropical Medicine and Hygiene 60, 7-13
221. World Health Organization (2011). World Malaria Report 2011. World Health Organization, Geneva, Switzerland
222. Young, J. A., Fivelman, Q. L., Blair, P. L., de la Vega, P., Le Roch, K. G., Zhou, Y., Carucci, D. J., Baker, D. A. and Winzeler, E. A. (2005). The Plasmodium falciparum sexual development transcriptome: A microarray analysis using ontology-based pattern identification. Molecular and Biochemical Parasitology 143, 67-79. doi: 10.1016/ j.molbiopara.2005.05.007
223. Zoungrana, A., Coulibaly, B., Sie, A., Walter-Sack, I., Mockenhaupt, F. P., Kouyate, B., Schirmer, R. H., Klose, C., Mansmann, U., Meissner, P. and Muller, O. (2008). Safety and efficacy of methylene blue combined with artesunate or amodiaquine for uncomplicated falciparum malaria: A randomized controlled trial from Burkina Faso. PLoS ONE 3, e1630. doi: 10.1371/journal. pone.0001630